Bone Marrow Transplant Research Review, Issue 6

In this issue:

Outpatient ASCT for lymphoma receiving reduced-intensity conditioning
COVID-19 in HSCT recipients
Third-party BK virus-specific CTL therapy for haemorrhagic cystitis after allo-SCT
PTCy vs. ATG for GVHD prophylaxis in haploidentical HSCT for adult ALL
Allo-HSCT for therapy-related myeloid neoplasms after lymphoid malignancy treatment
Costimulation blockade with abatacept for acute GVHD prevention
Two decades of allo-HSCT with nonmyeloablative conditioning for haematological malignancies
Letermovir for preventing CMV reactivation after allo-HSCT

Please login below to download this issue (PDF)

Subscribe